Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Harrison

Showing results (31-40 of 218) with videos related to

Pageof 22
Sort By:
Expert Opinion on Pharmacotherapy|May 8, 2026
Targeted treatment of anemia in Myelofibrosis and the impact of jak inhibitorsIman Al Noumani, Claire Harrison
Current Hematologic Malignancy Reports|May 17, 2023
Pelabresib (CPI-0610): An Exciting Novel Drug for the Treatment of MyelofibrosisGuadalupe Ferreira Gomes, Claire Harrison
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
The role of JAK1/2 inhibitors in the treatment of chronic myeloproliferative neoplasmsClodagh Keohane, Ruben Mesa, Claire Harrison
Blood|December 25, 2023
How I treat myeloproliferative neoplasms in pregnancySusan Robinson, Monica Ragheb, Claire Harrison
Expert Opinion on Drug Safety|June 5, 2014
Safety evaluation of ruxolitinib for treating myelofibrosisSofia Galli, Donal McLornan, Claire Harrison
Critical Care (London, England)|March 30, 2010
New versus old blood - the debate continuesJohn Laurie, Duncan Wyncoll, Claire Harrison
Haematologica|February 2, 2013
JAK inhibitors: beyond spleen and symptoms?Francisco Cervantes, Ruben Mesa, Claire Harrison
Expert Review of Hematology|September 8, 2015
The use of JAK inhibitors for low-risk myelofibrosisSamah Alimam, Donal McLornan, Claire Harrison
Medical Oncology (Northwood, London, England)|September 18, 2007
Letter to editor. Re: "Effect of concomitant use of pentoxifylline (PTX) and alpha-tocopherol with radiotherapy on the clinical outcome of patients with stage IIIB non-small cell lung cancer"Lucy Jellett, Claire Harrison, Jonathan McAleese
The New England Journal of Medicine|October 6, 2017
Clonal Hematopoiesis and AtherosclerosisBruno Cassinat, Claire Harrison, Jean-Jacques Kiladjian
Pageof 22

Showing results (31-40 of 218) with videos related to

Sort By:
Pageof 22
Expert Opinion on Pharmacotherapy|May 8, 2026
Targeted treatment of anemia in Myelofibrosis and the impact of jak inhibitorsIman Al Noumani, Claire Harrison
Current Hematologic Malignancy Reports|May 17, 2023
Pelabresib (CPI-0610): An Exciting Novel Drug for the Treatment of MyelofibrosisGuadalupe Ferreira Gomes, Claire Harrison
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
The role of JAK1/2 inhibitors in the treatment of chronic myeloproliferative neoplasmsClodagh Keohane, Ruben Mesa, Claire Harrison
Blood|December 25, 2023
How I treat myeloproliferative neoplasms in pregnancySusan Robinson, Monica Ragheb, Claire Harrison
Expert Opinion on Drug Safety|June 5, 2014
Safety evaluation of ruxolitinib for treating myelofibrosisSofia Galli, Donal McLornan, Claire Harrison
Critical Care (London, England)|March 30, 2010
New versus old blood - the debate continuesJohn Laurie, Duncan Wyncoll, Claire Harrison
Haematologica|February 2, 2013
JAK inhibitors: beyond spleen and symptoms?Francisco Cervantes, Ruben Mesa, Claire Harrison
Expert Review of Hematology|September 8, 2015
The use of JAK inhibitors for low-risk myelofibrosisSamah Alimam, Donal McLornan, Claire Harrison
Medical Oncology (Northwood, London, England)|September 18, 2007
Letter to editor. Re: "Effect of concomitant use of pentoxifylline (PTX) and alpha-tocopherol with radiotherapy on the clinical outcome of patients with stage IIIB non-small cell lung cancer"Lucy Jellett, Claire Harrison, Jonathan McAleese
The New England Journal of Medicine|October 6, 2017
Clonal Hematopoiesis and AtherosclerosisBruno Cassinat, Claire Harrison, Jean-Jacques Kiladjian
Pageof 22